Association between IL28B polymorphisms and outcome of treatment for acute hepatitis C in HIV-patients

Completed

• Conditions: IL28B single nucleotide polymorfism (SNP); IL28B substitution; 10047438

• Registration Number: NL-OMON34931
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 19

Inclusion Criteria

all HIV-infected patients seen at the two outpatient clinics (UMCU and UMCG) (having been) treated with peginterferon-alfa mono-therapy for acute HCV.

Exclusion Criteria

none, it's a excisting cohort of 19 treated patients with acute HCV and HIV

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Association between IL28B SNPs and outcome of acute HCV treatment.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>